GX CJ7 GX CJ7 Pill - white four-sided, 14mm
Generic Name: lamivudine
Pill with imprint GX CJ7 GX CJ7 is White, Four-sided and has been identified as Epivir 150 mg. It is supplied by ViiV Healthcare Company.
Epivir is used in the treatment of Hepatitis B; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Epivir 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GX CJ7 GX CJ7

Epivir
- Generic Name
- lamivudine
- Imprint
- GX CJ7 GX CJ7
- Strength
- 150 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ViiV Healthcare Company
- Inactive Ingredients
-
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polysorbate 80,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
49702-0203 | ViiV Healthcare |
54868-3693 (Discontinued) | Physicians Total Care Inc. (repackager) |
54569-4221 | A-S Medication Solutions, LLC (repackager) |
52959-0508 | H.J. Harkins Company, Inc. (repackager) |
49999-0119 (Discontinued) | Lake Erie Medical and Surgical Supply (repackager) |
66267-0513 | Nucare Pharmaceuticals Inc. (repackager) |
Related images for "GX CJ7 GX CJ7"
More about Epivir (lamivudine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.